Renalka Syrup in the Treatment of Urinary Tract Infection

Forty patients with clinical diagnosis of urinary tract infection (UTI) were selected for the study. The X-ray for kidney ureter and bladder regions/ultrasonography were done in all cases and prostate gland was examined in elderly subject for evidence of benign prostatic hyperplasia. Antibiotics were withdrawn in all the patients. All the patients received Renalka syrup at a dose of 2 teaspoonfuls, twice daily (i.e. before breakfast and after dinner) for 2-4 weeks depending upon the clinical response. The patients with complicated UTI not responding to Renalka syrup in a week’s time were given appropriate antibiotics depending upon urinary pathogens and their sensitivity pattern. The factors responsible for complicated UTI were noted in each patient. The urine was culture positive in 32 (80%) patients. E. coli was the commonest organism. Proteus and Staphylococcus saprophyticus were seen in 1 and 3 patients respectively. However, urine was sterile in 8 (20%) patients. The combination of Renalka and antimicrobial was given in 9 (22.5%) patients with complicated UTI as they did not respond to Renalka alone in a week’s time. Twenty eight (70%) patients had a good clinical response to Renalka. The favourable clinical response was observed when Renalka syrup was combined with antibiotics in patients with complicated UTI. No adverse effects were seen in Renalka syrup therapy.